Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Regulations’), Hester Biosciences has informed that CARE Ratings ('CARE Ratings'), vide its letter dated 1st January 2024 (received electronically), has assigned and reaffirmed the ratings to the Company. The said reaffirmed ratings and the rating letter issued by the CARE Ratings is enclosed.
The above information is a part of company’s filings submitted to BSE.
